Skip to content

Revolution Medicines

US · RVMD #499 by market cap Listed 2020
161.20 +1.77 +1.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Revolution Medicines

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Founded
2004
CEO
Dr. Mark A. Goldsmith, M.D., PhD
Employees
883
Headquarters
Redwood City, California, United States of America
Fiscal year end
12-31
Website
revmed.com

Company profile

Exchange
US
Symbol
RVMD
Market-cap rank
#499
Listing date
2020-02-13
Market cap
34.87B
Float cap
31.94B
Shares out
216.29M
Float shares
198.15M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:24 · For reference only, not investment advice and not tailored to your situation.

Revolution Medicines discussion 0 comments

Add a comment